Sage Therapeutics, Inc.

SAGEDelisted Jul 31, 2025

Industry: Pharmaceutical Preparations
SEC CIK: 0001597553

SEC filings (opens in a new tab)

Sage Therapeutics, Inc. was delisted on Jul 31, 2025; its insiders filed their last Form 4 on Jul 31, 2025; 192 institutions reported holding it in 13F filings for Q2 2025, worth $445.6M in total; no superinvestor held it.

Q3 2024 vs. Q2 2024

How the institutions holding Sage Therapeutics, Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024 All holders in Q2 2024

13F holders of SAGE: Q2 2024 compared with Q3 2024
Measure	Q2 2024	Of which not filed for Q3 2024	Q3 2024	Change
Holders	196	1	177	−18
Shares	53.5M	5.22M	51.4M	+3.11M (+6.4%)
Value	$581.3M	$56.6M	$373.7M	−$150.9M (−28.8%)

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (15)

Institutions that held Sage Therapeutics, Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to SAGE in Q3 2024
Institution	Shares	Value	% of portfolio
BlackRock, Inc.	5,390,913	$38.9M	0.00%
Connor, Clark & Lunn Investment Management Ltd.	65,562	$473.4K	0.00%
ADAR1 Capital Management, LLC	51,650	$372.9K	0.06%
Intech Investment Management LLC	20,274	$146.4K	0.00%
Creative Planning	12,133	$87.6K	0.00%
Teacher Retirement System of Texas	11,322	$82.0K	0.00%
Picton Mahoney Asset Management	2,842	$21.0K	0.00%
Capital Performance Advisors LLP	502	$3.62K	0.00%
AdvisorNet Financial, Inc	375	$2.71K	0.00%
True Wealth Design, LLC	193	$1.39K	0.00%
Sterling Capital Management LLC	189	$1.36K	0.00%
Truvestments Capital LLC	39	$282	0.00%
Massmutual Trust Co FSB	37	$267	0.00%
FSA Wealth Management LLC	35	$253	0.00%
Hemington Wealth Management	8	$0	0.00%

Sold out (33)

Institutions that held Sage Therapeutics, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of SAGE in Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
Cubist Systematic Strategies, LLC	489,089	$5.31M
Group One Trading, L.P.	399,305	$4.34M
Granahan Investment Management Inc	347,529	$3.77M
Capital Fund Management S.A.	196,543	$2.13M
Baker Bros. Advisors LP	171,026	$1.86M
J. Goldman & Co LP	116,842	$1.27M
Marshall Wace, LLP	108,439	$1.18M
Gsa Capital Partners LLP	78,749	$855.0K
Standard Life Aberdeen plc	64,801	$703.7K
Baillie Gifford & Co	63,333	$687.8K
XTX Topco Ltd	48,249	$524.0K
Wellington Management Group LLP	39,645	$430.5K
Twinbeech Capital LP	38,114	$413.9K
State of Wisconsin Investment Board	37,015	$402.0K
Capstone Investment Advisors, LLC	34,067	$370.0K
Tudor Investment Corp Et Al	29,963	$325.4K
Man Group plc	25,903	$281.3K
Dark Forest Capital Management LP	22,245	$241.6K
Y-Intercept (Hong Kong) Ltd	22,094	$239.9K
Point72 Asia (Singapore) Pte. Ltd.	21,806	$236.8K
Pennant Investors, LP	17,500	$190.1K
Vident Advisory, LLC	16,528	$179.5K
Point72 (DIFC) Ltd	14,097	$153.1K
Pinnacle Wealth Planning Services, Inc.	11,908	$129.3K
Cornercap Investment Counsel Inc	10,935	$118.8K
Lazard Asset Management LLC	8,589	$93.0K
Point72 Asset Management, L.P.	6,200	$67.3K
Headlands Technologies LLC	3,916	$42.5K
Danske Bank A/S	3,434	$37.3K
Pacer Advisors, Inc.	701	$7.61K
Lindbrook Capital, LLC	459	$4.99K
Private Wealth Management Group, LLC	95	$1.03K
Ancora Advisors, LLC	75	$814

Not filed for Q3 2024 yet (1)

Institutions that held Sage Therapeutics, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding SAGE in Q2 2024 that haven't filed for Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
BlackRock Inc.	5,215,589	$56.6M